Cases & Deals

Medco Research obtains summary judgment in securities fraud action

Clients Medco Research, Inc.

Jones Day represented Medco Research, Inc. in a securities fraud class action alleging that Medco misled investors concerning the prospects of FDA approval for a new drug. Summary judgment was granted in favor of Medco by the district court and affirmed on appeal by the Seventh Circuit.

Lasalle, et al. v. Medco Research, Inc., et al., No. 93-CIV-5381 (N.D. Ill.) aff'd, No. 96-2345 (7th Cir.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.